EMEA-000205-PIP02-11-M05
Key facts
| Invented name |
|
| Active substance |
Ceftobiprole medocaril (sodium)
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0529/2021
|
| PIP number |
EMEA-000205-PIP02-11-M05
|
| Pharmaceutical form(s) |
Powder for concentrate for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of pneumonia
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Basilea Pharmaceutica International Ltd
E-mail: medical.information@basilea.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|